[HT-11-1] パーキンソン病および類縁疾患における中枢画像バイオマーカー
Biomarkers related to the diagnosis and progression of Parkinson's disease are significant for early diagnosis including prodromal stage, prognosis, and development of novel therapies. Even now, there are excellent biomarkers, and although diagnostic criteria for the prodromal stage have been proposed, improvement in diagnostic sensitivity and specificity is inevitable. Based on such a background, recent advances in visualization technology using MRI and nuclear medicine, a more in-depth understanding of the effects of gut microbiota on the pathology, advances in blood biomarker measurement technology such as α-synuclein, and skin pathology are something amazing. In this session, symposists who are specialists in each field will provide the latest information and knowledge. We hope young researchers will envision the direction and potential of future research and encourage their research minds.
Dr. Taku Hatano received his MD degree from Juntendo University in 1999.
He received his PhD from Juntendo University in 2007 and was appointed Assistant Professor of Neurology at Juntendo University in the same year.
Since 2011, he has been Associate Professor of Neurology at Juntendo University.
His main research interests include the MRI neuroimaging and biomarkers of Parkinson’s disease.
DETAILS OF AUTHORIZATION TO PRACTICE MEDICNE OR OTHER SPECIALITY
National examination for medical practitioners, 1999, Medical Doctor
Japanese Society of Internal Medicine, 2015, Internal Medicine Specialist
Japanese Society of Neurology, 2005, Neurology Specialist
Japan Society for Dementia Research, 2010, Dementia Specialist
MEMBERSHIP OF PROFESSIONAL ORGANIZATIONS
Japanese Society of Neurology
The Japanese Society of Internal Medicine
International Parkinson and Movement Disorder Society
Movement Disorder Society of Japan
Japan Society for Dementia Research
Japanese Society of Neurological Therapeutics
抄録パスワード認証
パスワードは抄録集に記載してあります。